Chelsea plummets on US FDA disclosure of Northera concerns
This article was originally published in Scrip
Executive Summary
In the spirit of the upcoming US President's Day, which celebrates the birthdays of George Washington and Abraham Lincoln, Chelsea Therapeutics decided it could not tell a lie, or at least, mislead investors during a presentation it made this week at the BIO CEO Investor conference in New York. But that honesty came with a price.